MedPath

A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic biopsy with the average of 18-cores to detect clinically significant prostate cancer

Not Applicable
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000025911
Lead Sponsor
Tokyo Metropolitan Police Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who MRI/US fusion-targeted and concurrent systematic biopsies were not performed

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath